Lanean...
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
Interferon beta is a well established disease-modifying agent used for relapsing-remitting multiple sclerosis. Despite treatment, a relevant proportion of patients continue to experience clinical (ie, relapses, worsening of disability) and magnetic resonance imaging (MRI) activity. Early identificat...
Gorde:
| Argitaratua izan da: | Degener Neurol Neuromuscul Dis |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7337239/ https://ncbi.nlm.nih.gov/pubmed/32669902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S42734 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|